Pearl Bio leverages advanced synthetic biology to develop next-generation biomaterials tailored for smart biologics. Their proprietary technology integrates genome and ribosome engineering, enabling the production of innovative biologics with a wide range of chemistries that were previously unattainable. This approach allows Pearl Bio to create template-directed biomaterials that possess customizable properties, enhancing their applicability in various biotechnological fields.

The company's manufacturing platform combines biological precision with extensive chemical diversity, facilitating the generation of a robust internal pipeline of products. This R&D platform not only supports the development of unique biomaterials but also opens up numerous partnership opportunities, positioning Pearl Bio as a key player in the biotechnology landscape. Their focus on creating versatile biomaterials underscores their commitment to advancing the capabilities of biologics in addressing complex challenges in healthcare and beyond.

United States

Pearl Bio is a synthetic biology company that builds next-gen biomaterials for smart biologics. Their manufacturing platform unites the precision of biology with the vast diversity of chemistry to create template-directed biomaterials.

Pearl Bio

Company Details